Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Boris Maleshev who wrote (3650)	10/31/2000 8:13:35 PM
From: Chi Wong	Read Replies (1) \| Respond to of 5665

Boris we don't have anything against shorts. If you can make money in either direction it's money any way you look at it. You'll find a few longs here who will go short from time to time but the majority simply go long because there's so much potential. Raging Bull has extremely high expectations, I can't deny that. The excitement feeds itself and before you know it everyone is choosing colors for their Porsches and Mercedes and talking about $200 clubs. Never-the-less all the excitement is based on a company with promising technology that so far appears to exhibit low toxicity.

To: Boris Maleshev who wrote (3650)	11/1/2000 7:47:29 AM
From: NCKEV	Read Replies (1) \| Respond to of 5665

Ok Boris IYO how much is IMGN worth or any company that has a cure for colon cancer? How about small cell lung cancer and lets add to that a technology platform that other leaders in their fields now pay millions of dollars to use. Lets say the cure word comes into play, Give me a number, how much is that worth based on about 40m shares outstanding with the offering. If you can imagine that you can see why there is so much enthusiam around this company, compared to its peers IMGN is still pretty darn cheap.